Terry Magnuson

Terry Magnuson discloses dealings in Pharmaceutical Product Development Inc to SEC (Form 4). The record holds 15 filings, for trades running from 3 January 2006 to 5 December 2011.

Sales make up the whole of the open-market record (5 sales, €581k). The rest of the record consists of 7 share grants and 2 option exercises. Since January 2011: no purchases and 1 sale on the market.

On 6 December 2011 came the latest disclosure, a transaction for €437k in Pharmaceutical Product Development Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.